VGF and amyotrophic lateral sclerosis: Using plasma samples (Fig 1A), we found that VGF C-terminus peptide levels were decreased in ALS patients at the advanced stage (percentage decrease: 16%, p<0.04) compared to controls and patients at the early stage.